Abstracts

Histology is a key element for the multidisciplinary diagnosis of fibrotic diffuse parenchymal lung diseases (f-DPLD) when the clinical–radiological setting of f-DPLD with high-resolution CT features diagnostic of usual interstitial pneumonia (UIP) are not present.

Exposure to pollen has been associated with an increased risk of respiratory symptoms in both allergic and nonallergic individuals. However, the association of pollen exposure with respiratory symptoms during infancy, a particularly vulnerable period for lung development, remains unclear.

Comprehending the rate at which ischaemic myocardium succumbs to necrosis following an abrupt occlusion of a coronary artery is crucial to understand the efficacy and benefits behind the time dependency in ST-elevated myocardial infarction (STEMI) management. Over decades, efforts to shave off life-saving minutes from STEMI care centred on reducing door-to-needle and door-to-balloon times.

Contemporary data suggest endurance athletes are at an increased risk of developing atrial fibrillation (AF) when compared with the general population. Cardioembolic events such as stroke are a well-established complication of untreated AF.

Staging cardiac damage in patients undergoing transcatheter aortic valve replacement (TAVR) has been proposed as a prognostic tool. Other authors have shown that these staging systems are related with mortality. The aim of this study was to perform an external validation of the predictive capacity of the staging system proposed by Généreux et al.

Globally, cardiovascular diseases remain the leading cause of death, taking an estimated 17.9 million lives each year. It is projected that the global burden of cardiovascular diseases will continue to rise.

The severe acute respiratory syndrome coronavirus 2 pandemic has already infected millions of people worldwide, with 5–10% of cases leading to severe pneumonia. Although the majority improve over time, some patients may progress to post-COVID-19 interstitial lung disease.

Anterior ischaemic optic neuropathy (AION) is the most common acute optic neuropathy in older patients. Its annual incidence is 2.3–10.2 cases per 100,000 persons over 50 years.